The global medical oxygen concentrators market size was USD 1.48 billion in 2023, calculated at USD 1.57 billion in 2024 and is projected to surpass around USD 2.82 billion by 2034, expanding at a CAGR of 6% from 2024 to 2034.
Medical Oxygen Concentrators Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Oxygen Concentrators Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Oxygen Concentrators Market Revenue and Volume, by Technology, 2024-2034
8.1.1 Pulse Dose
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Continuous Flow
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Others
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Medical Oxygen Concentrators Market Revenue and Volume, by Product, 2024-2034
9.1.1. Fixed
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Portable
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Medical Oxygen Concentrators Market Revenue and Volume, by Application, 2024-2034
10.1.1. Non-home Care
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Home Care
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Product (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)
12.1. Teijen
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. DeVilbiss Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AirSep
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Inogen
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Nidek Medical
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Invacare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. O2 Concepts
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Inova Labs
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Covidien
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Philips Respironics
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client